Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 AUD | +3.09% | 0.00% | -9.09% |
05-16 | PYC Therapeutics Completes Dosing for Eye Disease Trial; Shares Fall 5% | MT |
05-09 | Transcript : PYC Therapeutics Limited - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.09% | 302M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.28% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- PYC Therapeutics Secures US FDA Clearance to Start Retinitis Pigmentosa Trial